The mortality rates associated with oral cancer are in excess of 50% due to the late stage of detection, as accurate clinical adjuncts are not available.
Oralscan screens and detects early-stage epithelial cancers (SCC) by fluorescence and diffuse reflectance imaging.
Oral Cancer Screening Device
Disclaimer: The information shared in the document is provided by the startup. Sascan shall not be held responsible for the authenticity shared by the startup.